Stem Cell Research For Macular Degeneration In England

There is great potential for stem cell transplantation in age related macular degeneration amd and this article explores the latest research.

Stem cell research for macular degeneration in england.

The other patient had stargardt s macular dystrophy a rare hereditary disease that causes macular degeneration in adolescence. Treatment of macular degeneration using embryonic stem cell derived retinal pigment epithelium. Macular society is the trading name of the macular disease society. Experimental transplant uses eye cells grown in a lab and if successful could be used to treat hundreds of thousands of macular degeneration sufferers in uk.

The promise of using stem cells to combat age related macular degeneration and the demand for it was sufficient to launch an ambitious fundraising effort in 2014 at cu that resulted in successfully recruiting canto soler and creating cellsight. In the study researchers developed stem cells into cell types found within the eye and carefully injected the cells into specific locations within. Nearly three years ago 86 year old douglas waters developed severe vision problems he was diagnosed with severe wet age related macular degeneration amd a chronic eye disease that causes. Kuehl the macular degeneration patient.

A charity registered in england and wales 1001198 scotland sc042015. Results from a clinical study suggest the treatment is safe and effective. A company limited by guarantee registered in england no. 1123 isle of man.

Preliminary results in asian patients. Stem cell research for age related macular degeneration. Successful trial on patients using new stem cell based treatment for wet age related macular degeneration amd. In an extensive review of stem cell research experts writing in nature cell biology conclude that almost 30 years of research were needed to move forward.

Song wk park k m kim h j et al. Stem cell reports 2015 4. The study is a major milestone for the london project to cure blindness and could lead to an off the shelf treatment within five years.